 In 2020, the pharmaceutical company AstraZeneca; in collaboration with Oxford University, is contracting for 1 billion doses of the Institute's capacity for its COVID-19 vaccine.The products developed include tuberculosis vaccine Tubervac (BCG), Poliovac for poliomyelitis, and other vaccinations for the childhood vaccination schedule.As of 2009, the institute was developing an intranasal swine flu vaccine.